+41.1%
GSK vs PAYC
-47.2%
+88.3%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | PAYC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | +0.7% | -0.8% | -0.2% |
| 7D | -5.3% | -2.9% | -2.4% | -5.1% |
| 30D | -3.7% | -7.4% | +3.8% | -3.2% |
| 3M | -7.3% | +6.8% | -14.0% | -7.7% |
| 6M | -4.2% | +75.9% | -80.1% | -7.8% |
| YTD | +0.9% | +52.7% | -51.8% | -2.1% |
| 1Y | +7.3% | +52.5% | -45.3% | +4.1% |
| 3Y | +52.7% | +35.7% | +17.0% | +48.4% |
| All | +41.1% | -47.2% | +88.3% | +45.5% |
Cumulative growth
Daily Returns
Daily percentage return beside PAYC.
Daily Out/Under-Performance
Portfolio return minus PAYC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PAYC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded PAYC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling